{
    "2018-10-24": [
        [
            {
                "time": "2018-10-24",
                "original_text": "Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "pain study",
                        "JV",
                        "CNS drugs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Wednesday's ETF with Unusual Volume: XPH",
                "features": {
                    "keywords": [
                        "ETF",
                        "unusual volume",
                        "XPH"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Healthcare ETFs to Buy Ahead of Q3 Earnings",
                "features": {
                    "keywords": [
                        "healthcare ETFs",
                        "Q3 earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "How Analysts View Johnson & Johnson in October",
                "features": {
                    "keywords": [
                        "analysts",
                        "Johnson & Johnson",
                        "October"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Health Care Sector Update for 10/24/2018: LH, ALXN, TMO, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "health care sector",
                        "update",
                        "LH",
                        "ALXN",
                        "TMO",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative",
                "features": {
                    "keywords": [
                        "new pain drug",
                        "Pfizer",
                        "Eli Lilly",
                        "opioid alternative"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain",
                "features": {
                    "keywords": [
                        "Pfizer-Lilly",
                        "non-opioid drug",
                        "reduce",
                        "osteoarthritis pain"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr.",
                "features": {
                    "keywords": [
                        "CMTA",
                        "NDA filing",
                        "USNA",
                        "DERM",
                        "report data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}